Figure 2. Distribution of Mild, Moderate, and Severe Myopia Progression in atropine, 0.01%, and Placebo Groups at 6 and 12 Months.

Myopia progression from baseline if less than 0.50 D (mild), between 0.50 D and less than 1.00 D (moderate), and greater than 1.00 D (severe).